Lonza Group Ag Market Cap 2012-2019 | LZAGY

Lonza Group Ag market cap history and chart from 2012 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Lonza Group Ag market cap as of May 22, 2020 is $37.04B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $37.041B $0.978B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $161.796B 28.06
Medtronic (MDT) Ireland $126.941B 20.64
Stryker (SYK) United States $69.021B 22.40
Boston Scientific (BSX) United States $50.251B 23.63
Baxter (BAX) United States $44.091B 0.00
Terumo (TRUMY) Japan $28.057B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $26.322B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.470B 16.03
ResMed (RMD) United States $23.342B 36.84
Smith & Nephew SNATS (SNN) United Kingdom $17.880B 0.00
Sunny Optical Technology (SNPTF) China $15.213B 0.00
Bio-Rad Laboratories (BIO) United States $14.007B 63.76
Insulet (PODD) United States $12.117B 1200.50
Shandong Weigao Medical Polymer (SHWGF) China $7.417B 0.00
Perrigo (PRGO) Ireland $7.399B 13.24
Quidel (QDEL) United States $7.286B 57.26
Canopy Growth (CGC) Canada $6.813B 0.00
Hill-Rom Holdings (HRC) United States $6.659B 18.77
GN STORE NORD (GNNDY) Denmark $6.590B 0.00
William Demant Holdings (WILYY) Denmark $6.417B 0.00
Haemonetics (HAE) United States $5.439B 32.67
ICU Medical (ICUI) United States $3.980B 29.03
GW Pharmaceuticals (GWPH) United Kingdom $3.925B 0.00
Agios Pharmaceuticals (AGIO) United States $3.636B 0.00
Neogen (NEOG) United States $3.523B 59.67
NuVasive (NUVA) United States $3.220B 25.86
Envista Holdings (NVST) United States $3.020B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.826B 0.00
TG Therapeutics (TGTX) United States $2.406B 0.00
National Vision Holdings (EYE) United States $2.037B 35.24
AtriCure (ATRC) United States $1.994B 0.00
Aurora Cannabis (ACB) Canada $1.624B 0.00
Cardiovascular Systems (CSII) United States $1.306B 0.00
MacroGenics (MGNX) United States $1.247B 0.00
NanoString Technologies (NSTG) United States $1.173B 0.00
Aphria (APHA) Canada $1.080B 0.00
Phibro Animal Health (PAHC) United States $1.001B 19.96
Cerus (CERS) United States $0.971B 0.00
OraSure Technologies (OSUR) United States $0.923B 185.88
InMode (INMD) Israel $0.838B 17.70
Omeros (OMER) United States $0.837B 0.00
PetIQ (PETQ) United States $0.818B 23.62
DFB Healthcare Acquisitions (AHCO) United States $0.756B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.726B 52.03
VAREX IMAGING (VREX) United States $0.684B 16.99
Quanterix (QTRX) United States $0.681B 0.00
Meridian Bioscience (VIVO) United States $0.635B 23.92
Zynex (ZYXI) United States $0.631B 63.33
Vapotherm (VAPO) United States $0.557B 0.00
Surmodics (SRDX) United States $0.505B 60.88
Lantheus Holdings (LNTH) United States $0.505B 10.16
LeMaitre Vascular (LMAT) United States $0.503B 28.67
Owens & Minor (OMI) United States $0.463B 12.25
Repro-Med Systems (KRMD) United States $0.387B 325.00
Cytosorbents (CTSO) United States $0.378B 0.00
Utah Medical Products (UTMD) United States $0.333B 24.16
BioLife Solutions (BLFS) United States $0.328B 145.91
Viemed Healthcare (VMD) United States $0.323B 28.90
Neptune Wellness Solutions (NEPT) Canada $0.290B 0.00
Organigram Holdings (OGI) Canada $0.290B 0.00
HEXO (HEXO) $0.256B 0.00
Female Health (VERU) United States $0.241B 0.00
Chimerix (CMRX) United States $0.207B 0.00
Chembio Diagnostics (CEMI) United States $0.191B 0.00
Exagen (XGN) United States $0.175B 0.00
Bovie Medical (APYX) United States $0.157B 0.00
Evolus (EOLS) United States $0.151B 0.00
Surface Oncology (SURF) United States $0.148B 0.00
Fonar (FONR) United States $0.148B 13.08
Rockwell Medical (RMTI) United States $0.146B 0.00
United Health Products (UEEC) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) Canada $0.131B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.119B 0.00
MTech Acquisition (KERN) United States $0.119B 0.00
Brainsway (BWAY) Israel $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.077B 0.00
Capricor Therapeutics (CAPR) United States $0.077B 0.00
Wound Management Technologies (SMTI) United States $0.076B 0.00
Nephros (NEPH) United States $0.070B 0.00
United-Guardian (UG) United States $0.069B 16.01
GUARDION HEALTH (GHSI) United States $0.047B 0.00
Trinity Biotech (TRIB) Ireland $0.036B 0.00
ImmuCell (ICCC) United States $0.030B 0.00
NF Energy Saving (BIMI) China $0.026B 0.00
FSD PHARMA INC (HUGE) Canada $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.018B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Senestech (SNES) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00